These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36302288)

  • 1. Healthcare utilization among children with a history of neonatal opioid withdrawal syndrome: A matched cohort study.
    Malthaner LQ; Jetelina KK; Loria H; McLeigh JD
    Child Abuse Negl; 2022 Dec; 134():105934. PubMed ID: 36302288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.
    Shrestha S; Roberts MH; Maxwell JR; Leeman LM; Bakhireva LN
    Neurotoxicol Teratol; 2021; 86():106975. PubMed ID: 33766722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
    Wang Y; Berger L; Durrance C; Kirby RS; Kuo D; Pac J; Ehrenthal DB
    Obstet Gynecol; 2023 Sep; 142(3):603-611. PubMed ID: 37548391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal opioid use during pregnancy and the risk of neonatal opioid withdrawal syndrome in the offspring.
    Kristensen AW; Vestermark V; Kjærbye-Thygesen A; Eckhardt MC; Kesmodel US
    Acta Obstet Gynecol Scand; 2024 Aug; 103(8):1522-1529. PubMed ID: 38700023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
    Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
    Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant Mortality Associated With Prenatal Opioid Exposure.
    Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
    JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization.
    Percy Z; Brokamp C; McAllister JM; Ryan P; Wexelblatt SL; Hall ES
    J Pediatr; 2020 Jul; 222():52-58.e1. PubMed ID: 32423682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
    Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
    J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome.
    Devlin LA; Hu Z; Ounpraseuth S; Simon AE; Annett RD; Das A; Fuller JF; Higgins RD; Merhar SL; Smith PB; Crawford MM; Cottrell LE; Czynski AJ; Newman S; Paul DA; Sánchez PJ; Semmens EO; Smith MC; Whalen BL; Snowden JN; Young LW;
    Matern Child Health J; 2023 Jun; 27(6):1030-1042. PubMed ID: 36905529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. There is reduced immunohistochemical staining of placental aromatase in severe neonatal opioid withdrawal syndrome.
    Townsel C; Odukoya E; Rae J; Thomas D
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9227-9233. PubMed ID: 34978244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.
    Radhakrishna U; Vishweswaraiah S; Uppala LV; Szymanska M; Macknis J; Kumar S; Saleem-Rasheed F; Aydas B; Forray A; Muvvala SB; Mishra NK; Guda C; Carey DJ; Metpally RP; Crist RC; Berrettini WH; Bahado-Singh RO
    Genomics; 2021 May; 113(3):1127-1135. PubMed ID: 33711455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
    Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Healthcare Utilization by Medicaid Enrolled Children with Neonatal Abstinence Syndrome.
    Taylor WM; Lu Y; Wang S; Sun LS; Li G; Ing C
    J Pediatr; 2020 Jun; 221():55-63.e6. PubMed ID: 32446493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk Factors Associated with the Occurrence of Neonatal Opioid Withdrawal Syndrome: A Review.
    Kelty E; Preen DB
    CNS Drugs; 2019 Nov; 33(11):1113-1120. PubMed ID: 31686408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
    Velez ML; Jordan CJ; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
    Isaac L; van den Hoogen NJ; Habib S; Trang T
    J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal Opioid Withdrawal Syndrome Treatment Guidelines and Birth Hospital Utilization.
    Hahn PD; Graham DA; Ozonoff A; Milliren CE
    Pediatrics; 2024 Jul; 154(1):. PubMed ID: 38899388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.